ANIP

ANI PHARMACEUTICALS INC · Healthcare · Market cap $1.6B

Insiders sold $2.2M net in the last 90 days ·5 sellers, 0 buyers· 10 of 11 sales under Rule 10b5-1 plans· latest Form 4 filed Oct 16, 2026

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$15.5M

reported sales (SEC code S)

Unique Insiders

12

in the rolling window

Latest filing

Oct 16, 2026

Lalwani Nikhil

ANI PHARMACEUTICALS INC (ANIP) has 76 SEC Form 4 filings (106 transaction rows) in the rolling window, disclosed by 12 distinct insiders. Most recent filing: Oct 16, 2026.

Inside the rolling window, 12 insiders at ANI PHARMACEUTICALS INC reported no open-market purchases and 48 open-market sales totaling $15.5M. The most active filer is SR. VP, GENERAL COUNSEL & SEC. Cook Meredith with 12 filings. Insiders have net sold $9.0M over the trailing 6 months. The most recent open-market filing is a sale of 5,400 shares by PRESIDENT & CEO Lalwani Nikhil, dated Oct 15, 2026, worth $388K.

  • Industry:Drug Manufacturers - Specialty & Generic
  • CEO:Nikhil Lalwani
  • Employees:970
  • HQ:Baudette, MN, US
  • IPO:2000-05-05
Source
Sale$388KOct 16SEC ↗
Sale$37KOct 14SEC ↗
Sale$208KSep 30SEC ↗
Sale$383KSep 16SEC ↗
Thoma JeanneFirst filing
Sale$72KSep 15SEC ↗
Sale$35KSep 15SEC ↗
Sale$207KSep 1SEC ↗
Lalwani NikhilFirst in 4 months
Sale$401KAug 26SEC ↗
Sale$38KAug 13SEC ↗
Gutwerg OriFirst in 3 months
Sale$243KAug 12SEC ↗
Sale$232KJul 30SEC ↗
Sale$41KJul 14SEC ↗
Sale$285KJul 7SEC ↗
Sale$240KJun 30SEC ↗
Sale$41KJun 15SEC ↗
HAUGHEY THOMASFirst filing
Sale$162KJun 11SEC ↗
CAREY STEPHEN P.First in 3 months
Sale$265KJun 9SEC ↗
Sale$321KMay 14SEC ↗
Sale$806KMay 14SEC ↗
Sale$39KMay 13SEC ↗
Sale$220KMay 13SEC ↗
Sale$36KMay 13SEC ↗
Lalwani NikhilFirst filing
Sale$4.3MMay 13SEC ↗
Sale$39KApr 13SEC ↗
Sale$36KMar 13SEC ↗
Showing 1–25 of 48
1 / 2

Earnings: last 7 quarters

EstimatedActual

Frequently asked questions

How many SEC Form 4 insider filings does ANIP have?

ANI PHARMACEUTICALS INC (ANIP) has 76 SEC Form 4 filings (106 transaction rows) in the rolling 365-day window, disclosed by 12 distinct insiders. Most recent filing: Oct 16, 2026.

When was the most recent SEC Form 4 filing for ANIP?

The most recent Form 4 filing for ANIP on Tracefour is dated Oct 16, 2026.

Who is the most active insider at ANIP?

The most active SEC Form 4 filer at ANIP in the rolling window is SR. VP, GENERAL COUNSEL & SEC. Cook Meredith, with 12 filings.

What is the net insider flow at ANIP over the last 6 months?

Over the trailing 180 days, insiders at ANIP have net sold $9.0M based on SEC Form 4 disclosures.

What is the total insider buy and sell value at ANIP in the current window?

Inside the rolling window, insiders at ANIP bought $0 and sold $15.5M based on SEC Form 4 filings.

Can I get alerts for ANIP insider trading?

Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at ANI PHARMACEUTICALS INC (ANIP). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.

Related companies

ANI PHARMACEUTICALS INC is in the Healthcare sector.